The habits you build during the adjustment period should continue throughout treatment
Single-Use, Disposable: Reduces risk of infection and supports safe diabetic care
Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure or treatment that is not addressed in the Payment Policy Manual is payable by Superior HealthPlan
For more information, contact us today!
Semaglutide Contains one mechanism of action: A GLP-1 agonist Decreases appetite, increases production of insulin, and increases satiety Used for patients seeking weight loss, patients suffering from Polycystic Ovarian Syndrome (PCOS), and those with insulin resistance
Patients recovering from COVID-19 can use these insights to fine-tune dosing and anticipate whether post-illness appetite changes reflect viral effects or underlying genetic variation in GLP-1 receptor function